BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36097900)

  • 41. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
    Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
    Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report.
    Tateishi K; Kiyoi M; Miyasaka M; Kawaji M; Nakanishi H; Furuta Y; Nishimatsu M; Takahashi Y; Nishikawa M; Nishimura Y
    Case Rep Oncol; 2023; 16(1):1482-1488. PubMed ID: 38028581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
    Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
    Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Case Report of a Rare ER+, PR- Pure Metaplastic Breast Squamous Cell Carcinoma with HER2 Overexpression.
    Adam SA; Kamaruddin KN; Abd Shukor N; Abdullah Suhaimi SN; Ismail F; Md Yasin M
    Am J Case Rep; 2023 Dec; 24():e941448. PubMed ID: 38048289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A Case of Metaplastic Squamous Cell Carcinoma of the Breast Successfully Treated with S-1].
    Yamamoto T; Nabeya M; Tokuhisa A; Kamei R; Sakamoto K; Kitamura Y; Ando S
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2137-2139. PubMed ID: 32156857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Matrix-producing metaplastic carcinoma: a clinicopathologic and prognostic analysis of 16 cases with review of literature].
    Zhang Z; Bu H; Huang H; Zhang J; Lang Z; Zhao T; Wang J; Liao D; Wei B
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):528-32. PubMed ID: 25346122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma.
    Qiu Y; Chen Y; Zhu L; Chen H; Dai Y; Bao B; Tian L; Hao X; Wang J
    Breast J; 2022; 2022():2500594. PubMed ID: 36051469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A Case of Stage IV Metaplastic Breast Cancer in Which Primary Tumor Was Removed after Treatment with Anti-HER2 Systemic Therapy].
    Egawa C; Inatome J; Sakamoto T; Naito A; Murakami K; Katsura Y; Ohmura Y; Kagawa Y; Takeno A; Takeda Y; Murata K; Takatsuka Y; Goto T; Nagano T
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):154-156. PubMed ID: 29362339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
    Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
    [No Abstract]   [Full Text] [Related]  

  • 52. p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma.
    Guo S; Wang Y; Rohr J; Shang L; Ma J
    J Clin Pathol; 2021 Oct; 74(10):641-645. PubMed ID: 32873702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological significance of WT1 expression in invasive breast carcinoma with >90% mucinous component.
    Xu X; Bi R; Shui R; Yu B; Cheng Y; Tu X; Yang W
    J Clin Pathol; 2022 Dec; 75(12):832-836. PubMed ID: 34244341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
    Gonzalez-Angulo AM; Litton JK; Broglio KR; Meric-Bernstam F; Rakkhit R; Cardoso F; Peintinger F; Hanrahan EO; Sahin A; Guray M; Larsimont D; Feoli F; Stranzl H; Buchholz TA; Valero V; Theriault R; Piccart-Gebhart M; Ravdin PM; Berry DA; Hortobagyi GN
    J Clin Oncol; 2009 Dec; 27(34):5700-6. PubMed ID: 19884543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
    Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.
    Haroon S; Zia S; Shirazi UA; Ahmed O; Asghar IA; Diwan MA; Afzal A; Irfan M; Ali SJ; Hashmi AA
    Cureus; 2021 Apr; 13(4):e14347. PubMed ID: 33987039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological and therapeutic analysis of primary breast squamous cell carcinoma.
    Chen Z; An N; Zhang L; Cui H; Jiang Y; Zhang Y
    Gland Surg; 2022 Jan; 11(1):125-135. PubMed ID: 35242675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological features of metaplastic breast carcinoma.
    Hasdemir OA; Tokgöz S; Köybaşıoğlu F; Karabacak H; Yücesoy C; İmamoğlu Gİ
    Adv Clin Exp Med; 2018 Apr; 27(4):509-513. PubMed ID: 29558027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors Associated With Node-Positive Disease in Estrogen Receptor-Positive Breast Cancer Patients.
    Gallagher J; Elleson KM; Englander K; Chintapally N; Sun W; Whiting J; Laronga C; Lee MC
    J Surg Res; 2024 Mar; 295():327-331. PubMed ID: 38061237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Residual pure intralymphatic carcinoma component only (lymphovascular tumor emboli without invasive carcinoma) after neoadjuvant chemotherapy is associated with poor outcome: Not pathologic complete response.
    Lee H; Jang Y; Cho YA; Cho EY
    Hum Pathol; 2024 Mar; 145():1-8. PubMed ID: 38311186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.